Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-03-08

Clinical Trial Update: IV Acetaminophen in Children Undergoing Palatoplasty [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of intravenous acetaminophen in children undergoing palatoplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ofirmev (acetaminophen)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Cleft Palate | Phase 2 | Status: WITHDRAWN